Galcanezumab

Category: Migraine / Tension Headache



Galcanezumab Overview

Galcanezumab, marketed under the trade name Emgality, is a humanized monoclonal antibody used for the prevention of migraine.[1][2] It is directed against calcitonin-related polypeptides alpha and beta. This drug was developed by Eli Lilly & Co. As of July2017[update].[3] The drug was approved by the US FDA in September 2018, becoming the third marketed CGRP inhibitor for the United States.[4] See also Oth...

Read more Galcanezumab Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Galcanezumab

Recent Galcanezumab Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Galcanezumab
  • Injection: 120mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Galcanezumab or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 23 March 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA